Record overview
Status and phase
Status: TERMINATED
Phase: PHASE2
Sponsor: Jiangsu Simcere Pharmaceutical Co., Ltd.
Condition: Advanced Solid Tumor
NCT05148195
A Phase II Study of Envofolimab and BD0801 With/Without Chemotherapy in Patients With Advanced Solid Tumors
Public trial-level signal summary for this oncology Phase 2 record.
Signal summary
Public flags
Status signal: Registry Stop Signal
Timeline signals: stale_update_signal
Results signal: Low Signal
Operational burden: rare_population_signal
Stopped reason
Context when available
The study was terminated due to the sponsor's research and development strategy adjustment.